Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA
This article is from
The Cancer Letter
archive.
Vol. 23 No. 18 | May 9, 1997
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Gramm-Rudman Cut Facing NCI Could Take $85 Million
October 20, 1989
TCL Archive
Patients urge Medicare to allow an open formulary for cancer treatment.
October 15, 2004
TCL Archive
Cancer Panel Urges Improved Funding For Basic Science
June 16, 1995
TCL Archive
NCI to Fund 122 More Grants in FY04
March 28, 2003
TCL Archive
NCI Forms Task Force To Examine Marin County Breast Cancer Incidence
November 15, 2002
TCL Archive
Panel Unenthused About New Toxicity Testing Program
December 15, 1978